Want to join the conversation?
Biopharmaceutical company $GALE swung to a 2Q16 earnings from a loss last year, driven by higher fair value of warrants potentially settleable in cash and of contingent purchase price liability. Net income was $5.39MM or $0.03 per share compared to a loss of $15.66MM or $0.10 per share last year.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)